Table 1 Patients characteristics

Duration of AF

6.3 ± 9.3

8.0 ± 11.5

3.8 ± 3.0

<0.05

Age

62 ± 12

61 ± 14

64 ± 10

0.38

Sex

53 (67.1%)

35 (74.5%)

18 (56.3%)

0.14

Ishemic heart disease

9 (11.4%)

4 (8.5%)

5 (15.6%)

0.27

Arterial hypertension

58 (73.4%)

36 (76.6%)

22 (68.8%)

0.45

Diabetes

3 (3.8%)

0

3 (9.4%)

0.06

Treatment

- Amiodarone

60 (75.9%)

32 (68.1%)

28 (87.5%)

0.06

- Propafenone

19 (24.1%)

13 (27.7%)

6 (18.8%)

0.43

- Beta blocker

23 (29.1%)

17 (36.2%)

6 (18.8%)

0.13

-Angiotensin receptor blocker

5 (6.3%)

3 (6.4%)

2 (6.3%)

1.0

- ACE inhibitor

51 (64.4%)

32 (68.1%)

19 (59.4%)

0.48

- Statin

20 (25.3%)

9 (19.1%)

11 (34.4%)

0.19

Cholesterol levels (mmol/L)

5.1 ± 0.9

5.3 ± 1.1

4.9 ± 0.6

0.22

CRP (mg/L)

5.6 ± 7.4

5.1 ± 6.6

6.2 ± 8.6

0.61

Lp(a) (g/L)

0.21 ± 0.24

0.22 ± 0.23

0.19 ± 0.25

0.61

Ejection fraction (%)

51 ± 8

52 ± 8

50 ± 10

0.47

Mitral regurgitation

(stage 2 or higher)

14 (17.7%)

11 (23.4%)

3 (9.4%)

0.14

Left atrium dimension

5.2 ± 0.8

5.4 ± 0.7

5.1 ± 1.0

0.20